FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387472974> ?p ?o ?g. }

• W4387472974 abstract "Historic South African 5-year overall survival (OS) rates for Hodgkin lymphoma (HL) from 2000 to 2010 were 46% and 84% for human immunodeficiency virus (HIV)-positive and HIV-negative children, respectively. We investigated whether a harmonised treatment protocol using risk stratification and response-adapted therapy could increase the OS of childhood and adolescent HL.Seventeen units prospectively enrolled patients less than 18 years, newly diagnosed with classical HL onto a risk-stratified, response-adapted treatment protocol from July 2016 to December 2022. Low- and intermediate-risk patients received four and six courses of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD), respectively. High-risk patients received two courses of ABVD, followed by four courses of cyclophosphamide, vincristine, prednisone, and dacarbazine (COPDac). Those with a slow early response and bulky disease received consolidation radiotherapy. HIV-positive patients could receive granulocyte colony-stimulating factor and less intensive therapy if stratified as high risk, at the treating clinician's discretion. Kaplan-Meier survival analysis was performed to determine 2-year OS and Cox regression to elucidate prognostic factors.The cohort comprised 132 patients (19 HIV-positive, 113 HIV-negative), median age of 9.7 years, with a median follow-up of 2.2 years. Risk grouping comprised nine (7%) low risk, 36 (27%) intermediate risk and 87 (66%) high risk, with 71 (54%) rapid early responders and 45 (34%) slow early responders, and 16 (12%) undocumented. Two-year OS was 100% for low-risk, 93% for intermediate-risk, and 91% for high-risk patients. OS for HIV-negative (93%) and HIV-positive (89%) patients were similar (p = .53). Absolute lymphocyte count greater than 0.6 × 109 predicted survival (94% vs. 83%, p = .02).In the first South African harmonised HL treatment protocol, risk stratification correlated with prognosis. Two-year OS of HIV-positive and HIV-negative patients improved since 2010, partially ascribed to standardised treatment and increased supportive care. This improved survival strengthens the harmonisation movement and gives hope that South Africa will achieve the WHO Global Initiative for Childhood Cancer goals." @default.
• W4387472974 created "2023-10-11" @default.
• W4387472974 creator A5001325791 @default.
• W4387472974 creator A5004708465 @default.
• W4387472974 creator A5006297447 @default.
• W4387472974 creator A5007203436 @default.
• W4387472974 creator A5012960302 @default.
• W4387472974 creator A5014208533 @default.
• W4387472974 creator A5019058700 @default.
• W4387472974 creator A5023026944 @default.
• W4387472974 creator A5023770886 @default.
• W4387472974 creator A5045403219 @default.
• W4387472974 creator A5046264589 @default.
• W4387472974 creator A5046739375 @default.
• W4387472974 creator A5051372183 @default.
• W4387472974 creator A5052589956 @default.
• W4387472974 creator A5057326639 @default.
• W4387472974 creator A5067793495 @default.
• W4387472974 creator A5077283744 @default.
• W4387472974 creator A5078709434 @default.
• W4387472974 creator A5078710577 @default.
• W4387472974 creator A5081707367 @default.
• W4387472974 date "2023-10-09" @default.
• W4387472974 modified "2023-10-12" @default.
• W4387472974 title "Improved survival of children and adolescents with classical Hodgkin lymphoma treated on a harmonised protocol in South Africa" @default.
• W4387472974 cites W2051650384 @default.
• W4387472974 cites W2136449004 @default.
• W4387472974 cites W2153452448 @default.
• W4387472974 cites W2169224728 @default.
• W4387472974 cites W2542892190 @default.
• W4387472974 cites W2605199144 @default.
• W4387472974 cites W2944434778 @default.
• W4387472974 cites W3041423955 @default.
• W4387472974 cites W3090306116 @default.
• W4387472974 cites W3094866415 @default.
• W4387472974 cites W3112697301 @default.
• W4387472974 cites W3209657577 @default.
• W4387472974 cites W4284884158 @default.
• W4387472974 cites W4317567884 @default.
• W4387472974 doi "https://doi.org/10.1002/pbc.30712" @default.
• W4387472974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37814417" @default.
• W4387472974 hasPublicationYear "2023" @default.
• W4387472974 type Work @default.
• W4387472974 citedByCount "0" @default.
• W4387472974 crossrefType "journal-article" @default.
• W4387472974 hasAuthorship W4387472974A5001325791 @default.
• W4387472974 hasAuthorship W4387472974A5004708465 @default.
• W4387472974 hasAuthorship W4387472974A5006297447 @default.
• W4387472974 hasAuthorship W4387472974A5007203436 @default.
• W4387472974 hasAuthorship W4387472974A5012960302 @default.
• W4387472974 hasAuthorship W4387472974A5014208533 @default.
• W4387472974 hasAuthorship W4387472974A5019058700 @default.
• W4387472974 hasAuthorship W4387472974A5023026944 @default.
• W4387472974 hasAuthorship W4387472974A5023770886 @default.
• W4387472974 hasAuthorship W4387472974A5045403219 @default.
• W4387472974 hasAuthorship W4387472974A5046264589 @default.
• W4387472974 hasAuthorship W4387472974A5046739375 @default.
• W4387472974 hasAuthorship W4387472974A5051372183 @default.
• W4387472974 hasAuthorship W4387472974A5052589956 @default.
• W4387472974 hasAuthorship W4387472974A5057326639 @default.
• W4387472974 hasAuthorship W4387472974A5067793495 @default.
• W4387472974 hasAuthorship W4387472974A5077283744 @default.
• W4387472974 hasAuthorship W4387472974A5078709434 @default.
• W4387472974 hasAuthorship W4387472974A5078710577 @default.
• W4387472974 hasAuthorship W4387472974A5081707367 @default.
• W4387472974 hasBestOaLocation W43874729741 @default.
• W4387472974 hasConcept C126322002 @default.
• W4387472974 hasConcept C141071460 @default.
• W4387472974 hasConcept C143998085 @default.
• W4387472974 hasConcept C187212893 @default.
• W4387472974 hasConcept C2776305933 @default.
• W4387472974 hasConcept C2776694085 @default.
• W4387472974 hasConcept C2776755627 @default.
• W4387472974 hasConcept C2777132456 @default.
• W4387472974 hasConcept C2779429289 @default.
• W4387472974 hasConcept C2780964509 @default.
• W4387472974 hasConcept C50382708 @default.
• W4387472974 hasConcept C71924100 @default.
• W4387472974 hasConceptScore W4387472974C126322002 @default.
• W4387472974 hasConceptScore W4387472974C141071460 @default.
• W4387472974 hasConceptScore W4387472974C143998085 @default.
• W4387472974 hasConceptScore W4387472974C187212893 @default.
• W4387472974 hasConceptScore W4387472974C2776305933 @default.
• W4387472974 hasConceptScore W4387472974C2776694085 @default.
• W4387472974 hasConceptScore W4387472974C2776755627 @default.
• W4387472974 hasConceptScore W4387472974C2777132456 @default.
• W4387472974 hasConceptScore W4387472974C2779429289 @default.
• W4387472974 hasConceptScore W4387472974C2780964509 @default.
• W4387472974 hasConceptScore W4387472974C50382708 @default.
• W4387472974 hasConceptScore W4387472974C71924100 @default.
• W4387472974 hasLocation W43874729741 @default.
• W4387472974 hasLocation W43874729742 @default.
• W4387472974 hasOpenAccess W4387472974 @default.
• W4387472974 hasPrimaryLocation W43874729741 @default.
• W4387472974 hasRelatedWork W2068354603 @default.
• W4387472974 hasRelatedWork W2130595908 @default.
• W4387472974 hasRelatedWork W2291534125 @default.
• W4387472974 hasRelatedWork W2335762340 @default.
• W4387472974 hasRelatedWork W2887013637 @default.
• W4387472974 hasRelatedWork W2970608623 @default.

• next